Detalhe da pesquisa
1.
The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations.
Br J Cancer
; 127(1): 84-91, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35256754
2.
A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy.
Gynecol Oncol
; 155(2): 270-274, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31500890
3.
Somatic mutations in BRCA1&2 in 201 unselected ovarian carcinoma samples - single institution study.
Pol J Pathol
; 70(2): 115-126, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31556562
4.
Screening with magnetic resonance imaging, mammography and ultrasound in women at average and intermediate risk of breast cancer.
Hered Cancer Clin Pract
; 15: 4, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28265306
5.
CHEK2 mutations and the risk of papillary thyroid cancer.
Int J Cancer
; 137(3): 548-52, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25583358
6.
Relationship between the Expression of CHK2 and p53 in Tumor Tissue and the Course of Papillary Thyroid Cancer in Patients with CHEK2 Germline Mutations.
Cancers (Basel)
; 16(4)2024 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38398207
7.
Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 Carriers.
Nutrients
; 16(9)2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38732616
8.
High Resolution Melting analysis as a rapid and efficient method of screening for small mutations in the STK11 gene in patients with Peutz-Jeghers syndrome.
BMC Med Genet
; 14: 58, 2013 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-23718779
9.
Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma.
Cancers (Basel)
; 13(3)2021 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33530461
10.
Case report of a woman with monoclonal gammapathy and papillary thyroid carcinoma, diagnosed because of detection of CHEK2 (I157T) mutation in genetic examinations.
Endokrynol Pol
; 61(5): 502-6, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21049466
11.
Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course.
Cancers (Basel)
; 11(11)2019 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31703344
12.
Pleomorphic adenoma of salivary glands does not appear to be a BRCA-1-dependent tumour in a Polish cohort.
Anticancer Res
; 28(5B): 3011-3, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19031948
13.
BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study.
PLoS One
; 13(7): e0201086, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30040829
14.
The p.G534E variant of HABP2 is not associated with sporadic papillary thyroid carcinoma in a Polish population.
Oncotarget
; 8(35): 58304-58308, 2017 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28938557
15.
Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer.
J Clin Oncol
; 31(26): 3191-6, 2013 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23940229
16.
Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy.
J Clin Oncol
; 28(3): 375-9, 2010 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20008645